- Lobbying
- Lobbying by Prasco, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Sean D'Arcy | Cnsl to Rep Pease, 1992 |
Jamie Tucker | Leg cnsl to Rep Northup, 1999; leg cnsl to Rep Inglis, 1997-99; legal intern to Spkr Gingrich, 1996; leg aide to Sen Coverdell, 1993-94 |
John Gilliland | Intl trade cnsl, S Fin Comm, Feb 03-Jan 05; leg asst to Sen Lincoln, Jun 01-Feb 03 |
Jeff McMillen | Staff dir, H Ways & Means Subcomm on Sel Rev Measures, Mar 01-Mar 04; staff, H Ways & Means Subcom on Oversight, Jun 98-Mar 01 |
Brian Pomper | Ch Intl Trade Cnsl, Intl Trade Cnsl, Senate Fin |
Paul Scolese | Prof staff mbr to H Commerce Comm, 1998- 2000; Leg Asst, Leg Dir and Admin Asst to Rep Paxon, 1990-97 |
Janine Smith | Tax cnsl/leg asst to Sen Moseley Braun, 1996-98 |
Joel Jankowsky | n/a |
Taylor Jones | n/a |
Jorge Lopez | n/a |
Valerie White | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Pharmacy
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Pharmacy
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Pharmacy
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Pharmacy
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Pharmacy
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Pharmacy
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Pharmacy
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Pharmacy
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Pharmacy
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Pharmacy
Registration
Issue(s) they said they’d lobby about: Promoting consumer benefits of authorized generic drugs.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate